43-03? TELEGRAMS: PENSPEK. SYDNEY
v.0. BOX 41 ARTARMON. N.S.W.

9
THE DISTILLERS COMPANY BIOCHEMICALS

(AUSTRALIA PTY) LIMITED

Campbell Street, Artarmon,_ N.S. W.
. I 
. I 

OUR REF: .. 
i 29th November, 1961.

YOUR REF.





I WITHDRAWAL 0F 

Dear Doctor,

we reproduce below the text of a letter which has been sent to
medical and pharmaceutical journals published in Australia.

"During the past week The Distillers Company (Biochemicals) Limited
London, have received reports from two overseas sources which may associate
Thalidomide with harmful effects on the foetus in early pregnancy.

Although the evidence on which these reports are based is
circumstantial (there have been no reports arising in Great Britain, either
chemically or pharmacologically) The Distillers Company (Biochemicals) Limited
feel that, pending further investigation, they have no alternative but to
withdraw 'Distaval' from the market. They are also withdrawing other products
which contain Thalidomide, namely 'Valgis', 'Tensival' and 'Valgraine'.
Meanwhile, they are continuing to carry on pharmacological and other studies
of their own, to make every endeavour to learn the truth about this development

. . As a result of this decision, ?Distaval' and other products
gonfaiging Thalidomide are now being withdrawn from sale in Australia and New
ea an 

Yours faithfully,

THE 0181'an CCMPANY 
(AUSTRALIA PTY.) LIMITED.

 

 







f/r'

I


I
?1 (?nultk

l.

(2 ml